Overview

Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients

Status:
Completed
Trial end date:
2003-08-01
Target enrollment:
0
Participant gender:
All
Summary
To determine the safety and IOP-lowering ability of a test compound in patients with open-angle glaucoma or ocular hypertension.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Alcon Research
Criteria
Inclusion Criteria:

- Adult subjects of either sex and any race with open-angle glaucoma or ocular
hypertension;

- logMAR visual acuity not worse than 0.6.

Exclusion Criteria:

- Clinically relevant ophthalmic or systemic conditions may be excluded.